Verisk (VRSK) Analysis

This report is auto-generated by an AI stock research platform for informational purposes only. The content is for general information and research reference, and does not constitute financial advice. Data may lag or be incomplete. Always conduct your own research and consult qualified professionals before making any financial decisions. # [Qiltrack AI] Verisk Analytics Inc (VRSK) 3-Minute Overview ### 🎯 Layer 1: 30-Second Key Takeaways > **💡 One-Sentence Summary** > > Simply put, Verisk is a data-and-analytics toll booth for the insurance industry—selling mission-critical risk information and software that customers tend to keep using year after year. > **📍 Basic Profile** > > Market Cap **$22.37 billion** · Professional Services / Insurance Data Analytics · NASDAQ NMS - GLOBAL MARKET · Price **$174.99** > **⚡ 3 Things You Should Know** > > 1. 💰 Quietly excellent business: Verisk runs with very high margins—gross margin near 70% and net margin around 29%—which tells you this is a data business with real pricing power, not a low-quality services shop. > > 2. 📈 Good business, not a hyper-growth story: Revenue growth has been positive but modest, with Q1 sales up about 3.9% and 3-year revenue growth around 7.2%, so the appeal here is more “steady compounder” than “explosive upside.” > > 3. ⚠️ Balance sheet optics need context: Debt-to-equity looks extremely high and price-to-book is distorted because equity is very small, so this is not an ideal stock to judge by book value metrics; the more useful question is whether cash flow stays durable enough to support leverage. > **🎯 Quick Health Check** > > | Dimension | Rating | Details | > |-----------|--------|---------| > | Profitability | Strong💪 | Net margin 29.34%, operating margin 43.55% | > | Growth Rate | Steady📈 | 3-year revenue growth 7.16%, recent quarter growth modest | > | Financial Health | Moderate💛 | Current ratio 1.02, debt-to-equity elevated at 15.33 | > | Valuation | Fair | PE 25.20x, reasonable for a high-quality data franchise but not cheap | --- ### 📋 Layer 2: 2-Minute Deep Dive #### 📊 How Does This Company Make Money? **Business Model in One Sentence:** Verisk sells data, analytics, models, and workflow tools to insurers and other enterprise customers, making money mainly through recurring subscriptions, data access, and software-like service contracts. **Revenue Breakdown:** | Business | Share | Trend | Comment | |----------|-------|-------|---------| | Insurance data & analytics | [Data unavailable] | ↑ | Core engine of the business and likely the main reason margins stay high | | Other analytics / solutions | [Data unavailable] | → | Smaller contribution, but supports cross-selling and stickiness | **Profitability Metrics:** | Metric | Value | Ranking | Interpretation | |--------|-------|---------|----------------| | Gross Margin | 69.98% | Top tier | Very strong for a data business; suggests scalable products and limited delivery cost | | Net Margin | 29.34% | Top tier | A large share of revenue turns into profit, which is what you want from a subscription-like analytics model | | ROE | 324.28% | [Distorted by low equity] | Looks extraordinary, but book equity is likely very small, so this number overstates operating quality | --- #### 📈 How's the Growth? **Growth Assessment:** Steady Growth | Metric | Latest | vs Last Year | Trend | |--------|--------|--------------|-------| | Revenue Growth | 3.9% | [Data unavailable] | Slowing / moderate | | Profit Growth | [Data unavailable] | [Data unavailable] | [Data unavailable] | **Growth Quality:** > What’s interesting is that the recent quarter points to modest, not flashy, expansion. That’s not necessarily bad—Verisk’s kind of business is often valued for resilience and retention more than raw speed. In other words, this looks like genuine operating growth from a sticky customer base, but the market probably won’t reward it with a premium multiple unless growth re-accelerates. --- #### 💰 Financial Health Check **One Sentence:** Think of it like someone with a very reliable paycheck and strong free cash generation, but also a fairly leveraged balance sheet and not much room for working-capital mistakes. | Metric | Value | Safe Zone | Assessment | |--------|-------|-----------|------------| | Debt Ratio | Debt-to-equity 15.33 | <60% safe | ⚠️High | | Current Ratio | 1.02 | >1.5 healthy | ⚠️Tight | | Cash Flow | Cash flow/share $6.28 | >0 | ✅Positive | **Worth noting:** interest coverage of 8.43x says the company can still service debt reasonably well, so this is not flashing distress. The issue is more balance-sheet flexibility than solvency. --- #### 🏷️ Is It Expensive Now? **Price Position (based on 52-week range):** - 52-Week Low: $155.94 - 52-Week High: $322.92 - Current: $174.99, Near the low | Position Range | Cheap Zone | Fair Zone | Pricey Zone | |----------------|------------|-----------|-------------| | Criteria | 0-33% | 33-66% | 66-100% | | **Current** | ●(11.4% position) | | | **Valuation Comparison:** | Comparison | Current | Reference | Assessment | |------------|---------|-----------|------------| | vs Own History | PE 25.20x | 5-year avg [Data unavailable] | [Data unavailable] | | vs Peers | PE 25.20x | Industry avg [Data unavailable] | [Data unavailable] | **What the Current Valuation is Betting On:** > Basically, the market still gives Verisk credit for being a high-quality, defensive compounder with sticky customers and strong margins—but at 25x earnings, it’s not pricing in explosive growth. It’s betting the company can keep compounding steadily, protect margins, and continue returning cash through dividends and buybacks. --- #### 📰 Any Recent News? | Date | Event | Impact | |------|-------|--------| | 2026-04-29 | Q1 2026 results: revenue beat, EPS modestly ahead/around expectations, full-year guidance reaffirmed | Positive — confirms business remains stable and management sounds confident about the year | | 2026-04-29 | Dividend increase and $1.5B share repurchase program highlighted in post-earnings coverage | Positive — signals confidence in cash generation and supports per-share returns | | 2026-05-28 | Management presented at Bernstein Strategic Decisions Conference | Neutral — keeps institutional attention on the name, but not a thesis-changer by itself | | 2026-05/06 | Shares down since earnings despite beat | Neutral/Negative — suggests investors want faster growth, not just “solid and steady” | --- ### 📊 Layer 3: Want More? 3-Minute Complete Analysis #### I. Detailed Financial Data **Profitability Trends:** | Metric | This Year | Last Year | Year Before | 3-Year Trend | |--------|-----------|-----------|-------------|--------------| | Gross Margin | 69.98% | [Data unavailable] | [Data unavailable] | [Data unavailable] | | Net Margin | 29.34% | [Data unavailable] | [Data unavailable] | [Data unavailable] | | ROE | 324.28% | [Data unavailable] | [Data unavailable] | [Data unavailable] | **Growth Trends:** | Metric | This Year | Last Year | Year Before | 3-Year Trend | |--------|-----------|-----------|-------------|--------------| | Revenue Growth | 3.9% recent quarter / 7.16% 3Y CAGR | [Data unavailable] | [Data unavailable] | → | | Profit Growth | [Data unavailable] | [Data unavailable] | [Data unavailable] | [Data unavailable] | | EPS Growth | 2.61% (3Y) | [Data unavailable] | [Data unavailable] | → | --- #### II. Earnings Track Record **Last 4 Quarters vs Expectations:** | Quarter | EPS Expected | EPS Actual | Surprise | |---------|--------------|------------|----------| | 2026-03-31 | $1.77 | $1.82 | +2.74% Beat 😀 | | 2025-12-31 | $1.64 | $1.82 | +10.91% Beat 😀 | | 2025-09-30 | $1.74 | $1.72 | -0.97% Miss 😟 | | 2025-06-30 | $1.81 | $1.88 | +4.04% Beat 😀 | **Earnings Trend Interpretation:** Three beats in the last four quarters is a good sign that execution is generally dependable. What you might care about, though, is that the beats are not translating into major stock excitement lately, which usually means expectations around future growth are still muted. --- #### III. What the Market Thinks **Analyst Ratings:** | Rating | Count | Percentage | |--------|-------|------------| | Strong Buy/Buy | 14 firms | 53.8% | | Hold | 11 firms | 42.3% | | Sell | 1 firm | 3.8% | **Target Price:** [Data unavailable] **vs Current Price:** [Data unavailable] **Insider Activity:** Net selling in the past 3 months appears modest and largely tied to option exercise/activity rather than aggressive discretionary dumping > Insider selling by itself isn’t automatically bearish, especially when codes show option exercises (“M”) and related sales (“S”). There were also several stock awards (“A”), so I wouldn’t overread this unless selling broadens materially. --- #### IV. Key Risk Alerts **3 Risks to Watch:** 1. **Growth Risk:** Revenue growth is solid but not fast → If growth stays in the low-single-digit range, the stock may struggle to re-rate higher even with strong margins. 2. **Leverage / Balance Sheet Risk:** Debt-to-equity is very high and liquidity is only just above 1x → If cash generation weakens or rates/refinancing terms worsen, financial flexibility could tighten. 3. **Valuation Compression Risk:** This is still priced like a quality compounder at 25x earnings → If investors rotate away from defensive quality names, multiple contraction could offset business performance. --- ### 🎬 Summary & Next Steps > **📝 Three-Sentence Summary** > > **What it is:** Verisk is a high-margin insurance analytics and data platform with a sticky customer base and recurring-like economics. > > **Key strength:** Its biggest advantage is that the business converts revenue into profit and cash extremely well, which supports dividends, buybacks, and resilience. > > **Key risk:** The main concern is that growth looks steady rather than exciting, while leverage and a still-respectable valuation leave less room for disappointment. --- > **🔍 Want to Learn More?** > > • Want to know if this company has a strong moat? → Try【Buffett Mode】for deeper analysis > > • Want to check for hidden landmines? → Try【Muddy Mode】for risk screening > > • Is this a growth stock? Want to calculate if it's worth the bet? → Try【Musk Mode】for analysis